Jul 11 |
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
|
Jul 10 |
Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
|
Jul 10 |
AbbVie names new R&D head
|
Jul 10 |
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
|
Jul 10 |
AbbVie names new R&D head; Arcutis eczema cream approved
|
Jul 9 |
The 7 Best Warren Buffett Stocks to Buy in July 2024
|
Jul 8 |
The Smartest Dividend Stocks to Buy With $250 Right Now
|
Jul 7 |
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
|
Jul 4 |
AbbVie Q2 Preview: Upgrade To Buy - Better Late Than Never
|
Jul 3 |
AbbVie Q2 IPR&D expenses to lower EPS by $0.52
|